AC133+ umbilical cord blood progenitors demonstrate rapid self-renewal and low apoptosis

Umbilical cord blood (UCB) provides immediate access to haemopoietic stem/progenitor cells (HSPC) but low cell number restricts use in full adult bone marrow reconstitution. This study investigated early ex vivo expansion kinetics of UCB AC133(+) cells (2-4 x 10(4)/ml), mononuclear cells (MNC, 1-2 x 10(6)/ml) and AC133negative cells (AC133(neg), 2-4 x 10(4)/ml) in stroma-free 8 d liquid culture (fetal bovine serum-supplemented Iscove's-modified Dulbecco's medium (IMDM) with either K36EG [c-Kit ligand, interleukin 3 (IL-3), IL-6, erythropoietin, granulocyte colony-stimulating factor] or TPOFL (thrombopoietin, Flt-3 ligand). Cell enumeration, apoptosis assay and AC133/CD34/ CD38 antigen immunophenotyping were performed at d 0, 3, 5 and 8. All three cell populations went through a proliferation lag phase between d 3 and d 5. AC133(+) cells recovered better from lag phase with significantly higher fold increase (FI) when compared with MNC and AC133(neg) populations (K36EG FI: 15.04 +/- 5.46; TPOFL FI: 8.59 +/- 2.92, P <0.05). After 8 d, populations lacking AC133(+) cells were significantly more inclined to undergo apoptosis under proliferative conditions (P <0.01). Also, when compared with K36EG, 8 d TPOFL-expanded AC133(+) cells encompassed a significantly higher percentage of AC133(+) and CD34(+) early HSPC (K36EG: 20.50 +/- 2.36; TPOFL: 47.00 +/- 7.69; P <0.05). In conclusion, TPOFL synergism demonstrated the potential for AC133(+) HSPC ex vivo expansion inducing self-renewal, early HSPC maintenance and promoting cell survival status.